These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1576677)

  • 1. Synthesis and optical resolution of an antiallergic agent KW4099 with thromboxane A2 antagonistic activity.
    Sugaya T; Kuge Y; Tomioka S; Tamaki K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):238-9. PubMed ID: 1576677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic optical resolution of dibenzoxepins and its application to an optically active antiallergic agent with thromboxane A2 receptor antagonistic activity.
    Kuge Y; Shioga K; Sugaya T; Tomioka S
    Biosci Biotechnol Biochem; 1993 Jul; 57(7):1157-60. PubMed ID: 7763987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dibenz[b,e]oxepin derivatives: novel antiallergic agents possessing thromboxane A2 and histamine H1 dual antagonizing activity. 1.
    Ohshima E; Takami H; Harakawa H; Sato H; Obase H; Miki I; Ishii A; Ishii H; Sasaki Y; Ohmori K
    J Med Chem; 1993 Feb; 36(3):417-20. PubMed ID: 8093908
    [No Abstract]   [Full Text] [Related]  

  • 4. Analogs of phenothiazines. 5. Synthesis and neuropharmacological activity of some piperidylidene derivatives of thioxanthenes, xanthenes, dibenzoxepins, and acridans.
    Kaiser C; Fowler PJ; Tedeschi DH; Lester BM; Garvey E; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):57-62. PubMed ID: 4808470
    [No Abstract]   [Full Text] [Related]  

  • 5. Biaryl axis as a stereochemical relay for the enantioselective synthesis of antimicrotubule agents.
    Joncour A; Décor A; Thoret S; Chiaroni A; Baudoin O
    Angew Chem Int Ed Engl; 2006 Jun; 45(25):4149-52. PubMed ID: 16688690
    [No Abstract]   [Full Text] [Related]  

  • 6. Rh/Pd catalysis with chiral and achiral ligands: domino synthesis of aza-dihydrodibenzoxepines.
    Friedman AA; Panteleev J; Tsoung J; Huynh V; Lautens M
    Angew Chem Int Ed Engl; 2013 Sep; 52(37):9755-8. PubMed ID: 23868558
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer.
    Bosch J; Bachs J; Gómez AM; Griera R; Écija M; Amat M
    J Org Chem; 2012 Jul; 77(14):6340-4. PubMed ID: 22731736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrylamide derivatives as antiallergic agents. III. Synthesis and structure-activity relationships of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]- and N-[4-(4-diphenylmethylene-1-piperidyl)butyl]-3-heteroarylacry lamides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):684-7. PubMed ID: 2752477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thromboxane A2 inhibition on osteogenic sarcoma cell-induced platelet aggregation.
    Mehta P; Lawson D; Ward MB; Lee-Ambrose L; Kimura A
    Cancer Res; 1986 Oct; 46(10):5061-3. PubMed ID: 3463411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
    Ohmori K; Hasegawa K; Tamura T; Miyake K; Matsubara M; Masaki S; Karasawa A; Urayama N; Horikoshi K; Kajita J; Hasegawa M; Taniguchi K; Komada T; Kawamoto Y
    Arzneimittelforschung; 2004; 54(12):809-29. PubMed ID: 15646365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.
    Rosentreter U; Böshagen H; Seuter F; Perzborn E; Fiedler VB
    Arzneimittelforschung; 1989 Dec; 39(12):1519-21. PubMed ID: 2624597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
    Ikemura T; Manabe H; Sasaki Y; Ishii H; Onuma K; Miki I; Kase H; Sato S; Kitamura S; Ohmori K
    Int Arch Allergy Immunol; 1996 May; 110(1):57-63. PubMed ID: 8645979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective synthesis and antioxidant activity of 3,4,5-substituted piperidine derivatives.
    Kim JH; Shyam PK; Kim MJ; Lee HJ; Lee JT; Jang HY
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3119-3121. PubMed ID: 27177825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thromboxane A2 and prevention of cardiovascular diseases].
    Schrör K
    Z Kardiol; 1992; 81 Suppl 4():185-9. PubMed ID: 1290297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
    Miki I; Ishii A
    Thromb Haemost; 1992 May; 67(5):582-4. PubMed ID: 1387741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
    Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
    J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First total synthesis of dioxepine bastadin 3.
    Pérez-Rodríguez S; Pereira-Cameselle R; de Lera AR
    Org Biomol Chem; 2012 Sep; 10(34):6945-50. PubMed ID: 22828961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.